Skip to main content
Fig. 1 | European Journal of Medical Research

Fig. 1

From: CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer

Fig. 1

The DEGs which had differential expression between normal LNCaP cells and EnzR LNCaP cells from GSE44905, GSE78201 and GSE150807 datasets. A The upregulated DEGs between normal LNCaP cells and EnzR LNCaP cells from GSE44905, GSE78201 and GSE150807. B The downregulated DEGs between normal LNCaP cells and EnzR LNCaP cells from GSE44905, GSE78201 and GSE150807

Back to article page